Acetylcholinesterase inhibitors for autistic spectrum disorders (Protocol)

Georgina R. Cox; Katrina J. Williams; Jade M. Woon; Richard Haslam; Alexandra M. Ure

doi:10.1002/14651858.CD013851

Acetylcholinesterase inhibitors for autistic spectrum disorders (Protocol)

Georgina R. Cox, Katrina J. Williams, Jade M. Woon, Richard Haslam, Alexandra M. Ure

Paediatrics Monash Health

Research output: Contribution to journal › Article › Research › peer-review

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the efficacy and harms of acetylcholinesterase inhibitors for individuals with the core features (social interaction, communication, and restrictive and repetitive behaviours) of ASD. Secondary objective This review will also assess the effects of acetylcholinesterase inhibitors on non-core features of ASD.

Original language	English
Article number	CD013851
Number of pages	17
Journal	Cochrane Database of Systematic Reviews
Volume	2021
Issue number	1
DOIs	https://doi.org/10.1002/14651858.CD013851
Publication status	Published - 23 Jan 2021

Access to Document

10.1002/14651858.CD013851

Link to publication in Scopus

Cite this

@article{4b4da908f0c740c295e4e889cb12ad95,

title = "Acetylcholinesterase inhibitors for autistic spectrum disorders (Protocol)",

abstract = "Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the efficacy and harms of acetylcholinesterase inhibitors for individuals with the core features (social interaction, communication, and restrictive and repetitive behaviours) of ASD. Secondary objective This review will also assess the effects of acetylcholinesterase inhibitors on non-core features of ASD.",

author = "Cox, {Georgina R.} and Williams, {Katrina J.} and Woon, {Jade M.} and Richard Haslam and Ure, {Alexandra M.}",

year = "2021",

month = jan,

day = "23",

doi = "10.1002/14651858.CD013851",

language = "English",

volume = "2021",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "John Wiley & Sons",

number = "1",

}

TY - JOUR

T1 - Acetylcholinesterase inhibitors for autistic spectrum disorders (Protocol)

AU - Cox, Georgina R.

AU - Williams, Katrina J.

AU - Woon, Jade M.

AU - Haslam, Richard

AU - Ure, Alexandra M.

PY - 2021/1/23

Y1 - 2021/1/23

N2 - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the efficacy and harms of acetylcholinesterase inhibitors for individuals with the core features (social interaction, communication, and restrictive and repetitive behaviours) of ASD. Secondary objective This review will also assess the effects of acetylcholinesterase inhibitors on non-core features of ASD.

AB - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the efficacy and harms of acetylcholinesterase inhibitors for individuals with the core features (social interaction, communication, and restrictive and repetitive behaviours) of ASD. Secondary objective This review will also assess the effects of acetylcholinesterase inhibitors on non-core features of ASD.

UR - http://www.scopus.com/inward/record.url?scp=85102551592&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD013851

DO - 10.1002/14651858.CD013851

M3 - Article

AN - SCOPUS:85102551592

VL - 2021

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

SN - 1469-493X

IS - 1

M1 - CD013851

ER -